Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
08/2002
08/29/2002US20020119932 RGD-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
08/29/2002DE10065478C1 Kreatin/Citronensäure-Verbindung, Verfahren zu ihrer Herstellung und Verwendung Creatine / citric acid combination, processes for their preparation and use
08/27/2002US6441176 Method for preparing sodium-hydrogen exchanger type 1 inhibitor
08/27/2002US6440903 Substituted 2,4-diamino-1,3,5-triazines as herbicides
08/22/2002WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/21/2002EP0802179B1 Substituted amidinonaphthyl ester derivatives
08/20/2002US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2001072685B1 Polyamine analogues as cytotoxic agents
08/15/2002CA2437405A1 Potassium channel openers
08/14/2002CN1364090A Medicinal compositions containing anti-Fas antibody
08/08/2002WO2002018327A3 Guanidinobenzamides as mc4-r agonists
08/07/2002EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
08/07/2002EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
08/07/2002EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
08/07/2002EP0781272B1 Synthesis of penta-substituted guanidines
08/07/2002CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2001070204A3 Highly selective inhibitors of the urokinase plasminogen activator
08/01/2002US20020103212 Pharmaceutical compositions containing anti-fas antibody
07/2002
07/31/2002EP1226115A1 Novel carbamates and ureas
07/31/2002EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
07/31/2002CN1361764A Aminoguanidine bicarbonate with particular properties and method for making same
07/24/2002EP1224165A1 Novel compounds
07/24/2002CN1360568A Diacylhydrazine derivs.
07/23/2002US6423748 Contact lenses antiseptic
07/18/2002WO2001072685A3 Polyamine analogues as cytotoxic agents
07/17/2002EP1222920A2 Mitochondria protecting agents for treating mitochondria associated diseases
07/17/2002CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
07/16/2002US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
07/16/2002US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents
07/16/2002US6420556 Multistage reaction for hypotensive agents or cardiotonic agents
07/11/2002WO2002053090A2 Medicinal association of a biguanine (metformin) and arginine
07/11/2002WO2002052957A1 Creatine/citric acid compound, method for the production of the same and the use thereof
07/11/2002US20020091260 Selective control of harmful plants in crops of useful plants
07/11/2002CA2435484A1 Medicinal association of a biguanide (metformin) and a carrier agent (arginine)
07/10/2002EP0517852B1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
07/10/2002CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
07/10/2002CN1087284C Method for preparing creatine or creatine-hydrate
07/09/2002US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
07/09/2002US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries
07/03/2002EP1219182A2 Better tasting L-amino acid salts and their manufacture
07/03/2002EP1218544A1 Methods for identifying rna binding compounds
07/03/2002CN1356998A Method of producing nitroguanidine-and nitroenamine derivatives
07/03/2002CN1356976A Therapeutically and/or nutritionaly enhanced derivatives of active ingredients and orally administrable compsns. contg. same
06/2002
06/27/2002US20020081360 Salts of L-amino acid having improved taste and their preparation
06/26/2002EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists
06/25/2002US6410667 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
06/25/2002US6410594 Viricides
06/19/2002EP1214294A1 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
06/19/2002EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors
06/18/2002US6407041 Substituted 2,4-diamino-1,3,5-triazines
06/13/2002WO2002028825A3 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
06/13/2002US20020072507 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono--and di-amino acid salts, and mono-and di-amino acid ester salts
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002CN1353689A 新的异羟肟酸衍生物 The new hydroxamic acid derivatives
06/06/2002WO2002004406A3 9-substituted minocycline compounds
06/06/2002US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases
06/06/2002US20020068701 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
06/05/2002EP1210330A1 Antibacterial agents
06/05/2002CN1352554A IL-8 receptor antagaonists
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002US6399819 Process for purifying creatine
06/04/2002US6399658 Composition containing ascorbic acid
06/04/2002US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists
05/2002
05/30/2002US20020065299 Administering for therapy of mitochondria medited disease
05/30/2002US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases
05/30/2002US20020065194 Guanidine compound and heat sensitive recording material
05/29/2002EP1208088A2 Fluorene derivatives as integrin inhibitors
05/29/2002EP1208078A1 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
05/28/2002US6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them
05/28/2002US6395713 Cationic lipidcationic lipid
05/23/2002WO2001098235A3 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
05/23/2002US20020061930 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
05/23/2002US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides
05/23/2002US20020061872 For oral administration or embedded or otherwise attached to medical devices for blood collection and/or treatment
05/22/2002EP1206447A1 Selective inhibitors of the urokinase plasminogene activators
05/15/2002EP1204633A1 Method for producing 1-methyl-3-nitroguanidine
05/14/2002US6388122 Tryptase inhibitor and novel guanidino derivatives
05/14/2002US6387949 Substituted urea compounds useful in pain management
05/14/2002US6387895 Bone disorders; cardiovascular disorders
05/14/2002CA2255665C Creatine pyruvates and method for their production
05/10/2002WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/08/2002EP1202995A1 Group(iii)-metal-hydrides with a guanidino-type ligand
05/08/2002EP1202956A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
05/08/2002EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors
05/08/2002CN1347874A Application of small dosage of aminoguanidine in anti-senility and preventing and treating senile diseases
05/08/2002CN1347693A Noval compound, its synthetizing process and therapeutic use
05/07/2002US6384277 Method of producing N-alkyl-N′-nitroguanidine
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020052422 Oral drug delivery compositions and methods
05/02/2002US20020052343 Salicylamides as serine protease inhibitors
05/01/2002CN1083702C Anti-bacterial amine derivs.
04/2002
04/30/2002US6380430 Biphenyl derivatives
04/30/2002US6380358 Guanidinylation reagents
04/30/2002US6380180 Potassium channel blocking agents
04/25/2002WO2002032392A1 Skin pore minimizers and skin elasticity improvers
04/25/2002US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels
04/24/2002EP1198456A2 Potassium channel openers
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 54